BusinessETST Announces Recruitment of Key Individuals for its Two Subsidiaries and the Leasing of a Manufacturing Facility to Produce its MSN-2 Medical Device.By Nasdaq OMXMar 14, 2017, 12:01 PM UTC
BusinessETST & Cannabis Therapeutics Inc. Announce its Cannabis Cannabinoid-Based Nutraceutical Patent & Generic Pharmaceutical Drug Timeline & Update.By Nasdaq OMXMar 6, 2017, 12:45 PM UTC
BusinessEarth Science Tech Inc. and Cannabis Therapeutics Inc. to hold High-Level R&D Strategy Session in Laval, Qc and announces Dr. Moutih Rafei, PhD, as a new member of the Advisory BoardBy Nasdaq OMXFeb 28, 2017, 1:00 PM UTC
BusinessEarth Science Tech Initiates its Cannabis Cannabinoid-Based Composition of its 2 New Pharmaceutical Drugs and 3 Nutraceutical Patent StudiesBy Nasdaq OMXFeb 23, 2017, 11:45 AM UTC
BusinessEarth Science Tech Strengthens Advisory Board with Four Distinguished Scientists and Doctors to Expand the Pharmaceutical & Nutraceutical Development of Cannabinoids' Therapeutic Indications, R&D, Technology, IP and TreatmentsBy Nasdaq OMXFeb 9, 2017, 12:45 PM UTC
BusinessTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 2017 BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 9, 2017, 12:02 PM UTC
BusinessTonix Pharmaceuticals to Present Breakthrough Therapy Designated-PTSD Program and Corporate Update at the 2017 BIO CEO & Investor ConferenceBy Nasdaq OMXFeb 9, 2017, 12:01 PM UTC
BusinessEarth Science Tech Announces New Wholly Owned Subsidiary, Cannabis Therapeutics Inc., to Develop & Launch its Cannabis Cannabinoid-Based Drugs & Nutraceuticals Using its Cannabinoid-Cannabidiol (CBD) Patent, IP and TechnologyBy Nasdaq OMXFeb 6, 2017, 12:45 PM UTC
